Roei David Mazor
Impact in
- Physiology top 5%
- Histiocytic Disorders and Treatments
- Immunology top 10%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Physiology 14
- Histiocytic Disorders and Treatments 14
-
- T-cell and B-cell Immunology 4
- Co-authors
- Yehuda Shoenfeld (4 shared papers)Alessandra Soriano (1 shared paper)Serena Colafrancesco (1 shared paper)Carlo Perricone (1 shared paper)Nancy Agmon‐Levin (1 shared paper)Liat Stoler‐Barak (2 shared papers)Ziv Shulman (3 shared papers)Britta Engelhardt (1 shared paper)
- Journals
- Transplantation and Cellular Therapy (3 papers)Leukemia (3 papers)Ultraschall in der Medizin - European Journal of Ultrasound (2 papers)Neurology (2 papers)Blood (1 paper)
- Partner nations
- IsraelUnited StatesFrance
In The Last Decade
Roei David Mazor
25 papers receiving 1k citations
Roei David Mazor's Hit Papers
Peers
Comparison fields: 5 of 74
- Physiology 492
- Immunology 163
- Toxicology 29
- Rheumatology 73
- Oncology 100
Countries citing papers authored by Roei David Mazor
This map shows the geographic impact of Roei David Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roei David Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roei David Mazor more than expected).
Fields of papers citing papers by Roei David Mazor
This network shows the impact of papers produced by Roei David Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roei David Mazor. The network helps show where Roei David Mazor may publish in the future.
Co-authors
The 25 scholars most cited alongside Roei David Mazor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era Hit paper breakdown → | 2020 | 263 |
| 2 | 2013 | 189 | |
| 3 | 2013 | 180 | |
| 4 | 2022 | 133 | |
| 5 | 2017 | 77 | |
| 6 | 2021 | 39 | |
| 7 | 2014 | 29 | |
| 8 | 2021 | 21 | |
| 9 | 2020 | 18 | |
| 10 | 2022 | 17 | |
| 11 | 2024 | 11 | |
| 12 | 2018 | 9 | |
| 13 | 2020 | 9 | |
| 14 | 2023 | 9 | |
| 15 | 2013 | 7 | |
| 16 | 2023 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2016 | 4 | |
| 20 | 2024 | 3 |
About Roei David Mazor
Roei David Mazor is a scholar working on Physiology, Immunology, Reproductive Medicine, Oncology and Pediatrics, Perinatology and Child Health, having authored 29 papers that have together received 1k indexed citations. Recurring topics across this work include Histiocytic Disorders and Treatments (14 papers), T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Fetal and Pediatric Neurological Disorders (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Myasthenia Gravis and Thymoma (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Physiology (492 citations), Immunology (163 citations), Toxicology (29 citations), Rheumatology (73 citations) and Oncology (100 citations). Roei David Mazor has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Yehuda Shoenfeld, Alessandra Soriano, Serena Colafrancesco, Carlo Perricone, Nancy Agmon‐Levin, Liat Stoler‐Barak, Ziv Shulman, Britta Engelhardt, Adi Biram and Sara W. Feigelson. Their work appears in journals such as Transplantation and Cellular Therapy, Leukemia, Ultraschall in der Medizin - European Journal of Ultrasound, Neurology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.